CG
FLNA

Cutler Group’s Filana Therapeutics FLNA Stock Holding History

Cutler Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$91K Sell
26,300
-27,000
-51% -$622K 0.03% 484
2023
Q4 		$105K Buy
53,300
+45,500
+583% +$961K 0.01% 1035
2023
Q3 		$15K Sell
7,800
-4,100
-34% -$81.3K ﹤0.01% 2240
2023
Q2 		$46K Sell
11,900
-12,900
-52% -$311K 0.01% 1342
2023
Q1 		$55K Sell
24,800
-95,600
-79% -$2.65M 0.01% 1284
2022
Q4 		$446K Buy
120,400
+17,700
+17% +$636K 0.04% 484
2022
Q3 		$1.15M Buy
102,700
+48,500
+89% +$1.31M 0.08% 269
2022
Q2 		$372K Sell
54,200
-32,200
-37% -$813K 0.03% 667
2022
Q1 		$760K Sell
86,400
-16,600
-16% -$703K 0.04% 502
2021
Q4 		$503K Sell
103,000
-33,500
-25% -$1.76M 0.02% 746
2021
Q3 		$1.01M Buy
136,500
+86,600
+174% +$7.23M 0.05% 465
2021
Q2 		$983K Buy
49,900
+4,600
+10% +$246K 0.05% 452
2021
Q1 		$176K Buy
45,300
+41,400
+1,062% +$1.63M 0.01% 1363
2020
Q4 		$6K Sell
3,900
-7,800
-67% -$69.6K ﹤0.01% 3555
2020
Q3 		$48K Sell
11,700
-10,000
-46% -$45.1K ﹤0.01% 1827
2020
Q2 		$2K Buy
+21,700
New +$98.4K ﹤0.01% 3822

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cutler Group's FLNA Position: Q1 2024 in Review

Cutler Group reduced its Filana Therapeutics (FLNA) stake by 63% in Q1 2024, selling an estimated $456K and leaving 11,700 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #251.

Cutler Group first reported a position in FLNA in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.46M in Q2 2021. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Cutler Group held 11,700 shares of Filana Therapeutics worth $237K as of Q1 2024.
  • Cutler Group sold 19,777 Filana Therapeutics shares in Q1 2024, an estimated $456K.
  • Filana Therapeutics made up 0.08% of Cutler Group's portfolio in Q1 2024, its #251 holding.
  • Cutler Group first reported a position in Filana Therapeutics in Q3 2016 and has held it in 18 quarters since.
  • Cutler Group's Filana Therapeutics position peaked at $1.46M in Q2 2021.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.